Strength: 1000 mcg/ml plus 2000 mcg/ml, 5 ml vial Dosage and administration: 0.10 ml injected 5 out of 7 nights a week before bedtime, on an empty stomach
Glucagon-like peptide 1 receptor agonists do not inherently increase the risk for hypoglycemia, but this risk is augmented when GLP-1 RAs are added to therapies known for causing hypoglycemia (i.e., sulfonylureas or insulin) [9]
2 The two dominant incretins are glucagon-like peptide-1 (GLP-1), secreted by enteroendocrine L cells (located in the ileum and colon), and glucose-dependent insulinotropic peptide (GIP), secreted by K cells (located mainly in the duodenum)
Most people see results within weeks, with continued improvement for up to six months
Track your progress and celebrate the small wins
NAD + depletion elevates the methylation of BDNF promoter, triggering the dissociation of the DNA methylation-sensitive nuclear factor CCCTC-binding factor (CTCF) and cohesin from the BDNF locus